These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17200222)

  • 1. BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
    Bibbins-Domingo K; Fernandez A
    Ann Intern Med; 2007 Jan; 146(1):52-6. PubMed ID: 17200222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.
    Temple R; Stockbridge NL
    Ann Intern Med; 2007 Jan; 146(1):57-62. PubMed ID: 17200223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BiDil for heart failure in black patients.
    Kahn JD
    Ann Intern Med; 2007 Aug; 147(3):215; author reply 215-6. PubMed ID: 17679713
    [No Abstract]   [Full Text] [Related]  

  • 4. BiDil for heart failure in black patients.
    Bibbins-Domingo K; Fernandez A
    Ann Intern Med; 2007 Aug; 147(3):214-5; author reply 215-6. PubMed ID: 17679712
    [No Abstract]   [Full Text] [Related]  

  • 5. Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients.
    Ellison GT; Kaufman JS; Head RF; Martin PA; Kahn JD
    J Law Med Ethics; 2008; 36(3):449-57. PubMed ID: 18840235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U.S. to review drug intended for one race.
    Saul S
    N Y Times Web; 2005 Jun; ():A1, A15. PubMed ID: 15966118
    [No Abstract]   [Full Text] [Related]  

  • 7. Misreading race and genomics after BiDil.
    Kahn J
    Nat Genet; 2005 Jul; 37(7):655-6. PubMed ID: 15990879
    [No Abstract]   [Full Text] [Related]  

  • 8. Bidil: recontextualizing the race debate.
    Séguin B; Hardy B; Singer PA; Daar AS
    Pharmacogenomics J; 2008 Jun; 8(3):169-73. PubMed ID: 18195727
    [No Abstract]   [Full Text] [Related]  

  • 9. The paradox of race in the Bidil debate.
    Crawley L
    J Natl Med Assoc; 2007 Jul; 99(7):821-2. PubMed ID: 17668653
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approves heart drug for black patients.
    Meadows M
    FDA Consum; 2005; 39(5):8-9. PubMed ID: 16419285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Ethnic drugs".
    Kahn J
    Hastings Cent Rep; 2005; 35(1):1 p following 48. PubMed ID: 15799501
    [No Abstract]   [Full Text] [Related]  

  • 12. Race-based medicine and justice as recognition: exploring the phenomenon of BiDil.
    Yu JH; Goering S; Fullerton SM
    Camb Q Healthc Ethics; 2009; 18(1):57-67. PubMed ID: 19091146
    [No Abstract]   [Full Text] [Related]  

  • 13. Race-based therapeutics.
    Bloche MG
    N Engl J Med; 2004 Nov; 351(20):2035-7. PubMed ID: 15533852
    [No Abstract]   [Full Text] [Related]  

  • 14. Gray area for new heart failure drug. Although the FDA approved BiDil for blacks with heart failure, it may work in anyone.
    Harv Heart Lett; 2005 Nov; 16(3):1-2. PubMed ID: 16363036
    [No Abstract]   [Full Text] [Related]  

  • 15. How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.
    Kahn J
    Yale J Health Policy Law Ethics; 2004; 4(1):1-46. PubMed ID: 15052858
    [No Abstract]   [Full Text] [Related]  

  • 16. F.D.A. approves a heart drug for African-Americans.
    Saul S
    N Y Times Web; 2005 Jun; ():C2. PubMed ID: 15981400
    [No Abstract]   [Full Text] [Related]  

  • 17. "Special treatment": BiDil, Tuskegee, and the logic of race.
    Reverby SM
    J Law Med Ethics; 2008; 36(3):478-84. PubMed ID: 18840239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing BiDil: is it black and white?
    Haga SB; Ginsburg GS
    J Am Coll Cardiol; 2006 Jul; 48(1):12-4. PubMed ID: 16814642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food & Drug Administration panel approves heart failure medication aimed at African-Americans.
    Pharmacogenomics; 2005 Jul; 6(5):455. PubMed ID: 16705760
    [No Abstract]   [Full Text] [Related]  

  • 20. Illuminating BiDil.
    Nat Biotechnol; 2005 Aug; 23(8):903. PubMed ID: 16082345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.